Genecentric

Developer of diagnostics for cancer classification and treatment

placeDurham, North Carolina, United States calendar_todayFounded 2011 groups19 employees language genecentric.com

Social engagement

Social engagement: 2.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Hatteras Venture Partners, LabCorp.

Investor typeCountShare
Venture capital350%
Private equity117%
Other / undisclosed233%

Recent activity

28 May 2026
Event
ASCO26
20 May 2026
Event
ASCO26
28 Apr 2026
Event
AACR26
Coming soon